, Volume 252, Issue 1, pp 49-53

Influence on erythropoietin levels of treatment with cisplatinum-endoxan

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Summary

Erythropoietin levels have been determined in 24 patients with different gynecologic malignancies, who were treated with cisplatinum and endoxan. A statistically highly significant decrease was demonstrated 2 h after starting treatment with a further significant decrease at 6 h. After 12 h the erythropoietin concentrations returned to values similar to those before treatment started.

Dedicated to Prof. Dr. P. Dittrich in honour of his 65th anniversary